MENU
+Compare
IDXX
Stock ticker: NASDAQ
AS OF
Apr 1, 04:59 PM (EDT)
Price
$418.44
Change
-$1.51 (-0.36%)
Capitalization
44.84B

IDXX IDEXX Laboratories Forecast, Technical & Fundamental Analysis

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock... Show more

IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IDXX with price predictions
Mar 31, 2025

IDXX's RSI Indicator ascending out of oversold territory

The RSI Oscillator for IDXX moved out of oversold territory on March 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 46 cases where IDXX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IDXX just turned positive on March 27, 2025. Looking at past instances where IDXX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IDXX advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

IDXX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IDXX as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

IDXX moved below its 50-day moving average on March 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IDXX crossed bearishly below the 50-day moving average on March 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDXX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IDXX entered a downward trend on March 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IDXX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (29.762) is normal, around the industry mean (23.715). P/E Ratio (52.873) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (5.079) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (12.195) is also within normal values, averaging (41.612).

View a ticker or compare two or three
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IDXX is expected to report earnings to rise 9.16% to $2.86 per share on April 30

IDEXX Laboratories IDXX Stock Earnings Reports
Q1'25
Est.
$2.86
Q4'24
Beat
by $0.23
Q3'24
Beat
by $0.11
Q2'24
Missed
by $0.45
Q1'24
Beat
by $0.11
The last earnings report on February 03 showed earnings per share of $2.62, beating the estimate of $2.39. With 133.17K shares outstanding, the current market capitalization sits at 44.84B.
A.I. Advisor
published General Information

General Information

a manufacturer of animal health products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One IDEXX Drive
Phone
+1 207 556-0300
Employees
11000
Web
https://www.idexx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRBG31.570.21
+0.67%
Corebridge Financial
IOSP94.75-0.45
-0.47%
Innospec
SSYS9.79-0.32
-3.21%
Stratasys Ltd
INBS1.44-0.07
-4.64%
Intelligent Bio Solutions
FENC6.09-0.41
-6.31%
Fennec Pharmaceuticals

IDXX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with MYGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+0.98%
MYGN - IDXX
48%
Loosely correlated
-0.11%
TFX - IDXX
40%
Loosely correlated
+0.28%
IQV - IDXX
40%
Loosely correlated
-0.61%
SNN - IDXX
40%
Loosely correlated
+1.14%
SONVY - IDXX
40%
Loosely correlated
-1.99%
More